1-4 of 4
Yoko Miura
Close
Sort by
Journal Articles

Induction of the NKG2D Ligands Expression by Histone Deacetylase Inhibitor and Its Impact on the Susceptibility of Leukemic Cells to the Cytolytic Activity of NKG2D-Expressing Cells.

Naoko Kato, Junji Tanaka, Junichi Sugita, Tomomi Toubai, Yoko Miura, Makoto Ibata, Yusuke Shono, Shuichi Ota, Takeshi Kondo, Masahiro Asaka, Masahiro Imamura
Journal: Blood
Blood (2006) 108 (11): 924.
https://doi.org/10.1182/blood.V108.11.924.924
Published: 2006
Journal Articles

Analysis of TREC (T Cell Receptor Excision Circles) Levels in CD94 Expressing CD8 T Cells in Chronic GVHD.

Noriaki Iwao, MD, Junji Tanaka, MD, Naoko Kato, MD, Takeshi Kondo, MD, Yoko Miura, MD, Tomomi Toubai, MD, Akio Shigematsu, MD, Keiichi Kondo, MD, Shuichi Ohta, MD, Masahiro Asaka, MD, Masahiro Imamura, MD
Journal: Blood
Blood (2005) 106 (11): 5367.
https://doi.org/10.1182/blood.V106.11.5367.5367
Published: 2005
Journal Articles

Expansion of Inhibitory NK Receptor (CD94/NKG2A)-Expressing CD8 T Cells from Various Blood Mononuclear Cells with Cytolytic Activity Against Primary Leukemic Cells.

Junji Tanaka, MD, Noriaki Iwao, MD, Tomomi Toubai, MD, Yoko Miura, MD, Naoko Kato, MD, Akio Shigematsu, MD, Keichi Kondo, MD, Shuichi Ota, MD, Masahiro Asaka, MD, Masahiro Imamura, MD
Journal: Blood
Blood (2004) 104 (11): 4967.
https://doi.org/10.1182/blood.V104.11.4967.4967
Published: 2004
Journal Articles

Cytolytic activity and regulatory functions of inhibitory NK cell receptor–expressing T cells expanded from granulocyte colony-stimulating factor–mobilized peripheral blood mononuclear cells

Junji Tanaka, Tomomi Toubai, Yutaka Tsutsumi, Yoko Miura, Naoko Kato, Shintarou Umehara, Kaoru Kahata, Akio Mori, Nobuyasu Toyoshima, Shuichi Ota, Takahiko Kobayashi, Masanobu Kobayashi, Masaharu Kasai, Masahiro Asaka, Masahiro Imamura
Journal: Blood
Blood (2004) 104 (3): 768–774.
https://doi.org/10.1182/blood-2003-11-3870
Published: 2004